Recombinant human erythropoietin promotes the acquisition of a malignant phenotype in head and neck squamous cell carcinoma cell lines in vitro - Wikidata - wikimedia - TriplyDB

Recombinant human erythropoietin promotes the acquisition of a malignant phenotype in head and neck squamous cell carcinoma cell lines in vitro

Recombinant human erythropoietin promotes the acquisition of a malignant phenotype in head and neck squamous cell carcinoma cell lines in vitro

http://www.wikidata.org/entity/Q34107767

about

Erythropoietin suppresses the activation of pro-apoptotic genes in head and neck squamous cell carcinoma xenografts exposed to surgical trauma.Erythropoietin and cancer: the unintended consequences of anemia correction Functional significance of erythropoietin in renal cell carcinoma.Erythropoietin-driven signalling and cell migration mediated by polyADP-ribosylation.Association between FBP1 and hypoxia-related gene expression in clear cell renal cell carcinoma Far-western blotting as a solution to the non-specificity of the anti-erythropoietin receptor antibody The tumor promoting roles of erythropoietin/erythropoietin receptor signaling pathway in gastric cancer.

P2860

Q34217187-258914C0-C469-47C7-8F8C-35F38CE2D38E Q34488415-E61640D1-C9B0-4C93-9FA0-D4AF88603B06 Q34543726-7890C8E1-6B59-4C52-810A-8E16C6FE2150 Q36387871-0B97E44E-48A2-493C-B714-0FD4F15C0D15 Q36954700-C3EAC9E4-DE7E-4E01-BD1E-2FFB0CD79572 Q37107771-14443AC1-8B29-4B52-9FEF-8FBE6D8C0AC0 Q53120576-7D695D09-FBE4-4CF6-8D81-8FF817B4110E

P2860

Recombinant human erythropoietin promotes the acquisition of a malignant phenotype in head and neck squamous cell carcinoma cell lines in vitro

http://www.wikidata.org/entity/Q34107767

description

2011 nî lūn-bûn

@nan

2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

Recombinant human erythropoiet ...... carcinoma cell lines in vitro

@ast

Recombinant human erythropoiet ...... carcinoma cell lines in vitro

@en

Recombinant human erythropoiet ...... carcinoma cell lines in vitro

@nl

type

label

Recombinant human erythropoiet ...... carcinoma cell lines in vitro

@ast

Recombinant human erythropoiet ...... carcinoma cell lines in vitro

@en

Recombinant human erythropoiet ...... carcinoma cell lines in vitro

@nl

prefLabel

Recombinant human erythropoiet ...... carcinoma cell lines in vitro

@ast

Recombinant human erythropoiet ...... carcinoma cell lines in vitro

@en

Recombinant human erythropoiet ...... carcinoma cell lines in vitro

@nl

P1433

Q34107767-17C09F45-2DED-4707-9139-F3B8833F5DEA

P1476

Q34107767-802B5AD8-173C-43DD-8CD5-B14DDA8B82FC

P2093

Q34107767-384F9D7F-73EB-440E-BC87-9F2E9285C570

Q34107767-9CDED324-246F-45F7-AA73-E1B51DB5D6DD

Q34107767-9F4D620D-0BF1-464C-852A-07FE553D5F5B

Q34107767-AD6588BF-0208-4F30-8073-816A10475E4A

Q34107767-D9726D20-62E2-473F-89B3-0F7B048B7001

Q34107767-E004E885-1C49-4BF5-9E52-6D7EA9D068A7

Q34107767-F9FB668D-43A7-4604-9F07-E98772C96B29

P2860

Q34107767-1384810E-ABE3-4F88-951A-778415FDFC4F

Q34107767-2C8A8511-3EEA-4EE1-AC58-088B1F2FB22F

Q34107767-34FD9C9D-9419-4828-B7E0-49FE9DCA50C1

Q34107767-3BD2B2B4-14D9-4E9B-8DDE-10D34FB8E8FD

Q34107767-43731A0C-DEFE-41B9-996D-9C5A99F83920

Q34107767-511ABE88-2F56-4B8A-B551-8C61EB48187F

Q34107767-522B9085-3D84-40C8-931D-F4639C7749A9

Q34107767-654E1E26-7354-48E2-A2F3-1E1015C1A222

Q34107767-6749482E-C70C-44BD-941E-DE8122A628D6

Q34107767-683D41D0-FA2C-4E67-8E1D-7FFDD8E0D995

P2888

Q34107767-999B6E91-8968-41A3-85B6-60E75F4A467B

P304

Q34107767-1A2918FB-9364-449A-A802-0E788BE41944

P31

Q34107767-5DB4BB5B-D5DB-48A6-8A81-B1B598C529E0

P356

Q34107767-78BD21BD-7496-4D37-9BBD-4135D1E02616

P478

Q34107767-4D3EC563-673D-4DC0-84AF-BE68652E9E80

P50

Q34107767-A9C61BF6-6EF4-42F0-9ED8-23E589AAE309

P577

Q34107767-050B3539-36D9-4BFA-A0C2-2933B908213F

P5875

Q34107767-423C8C72-71BF-4800-AAE1-06F11DE50469

P6179

Q34107767-A29F01DE-A462-4C56-8744-0965C0D44C12

P698

Q34107767-B17EB80C-CB85-4928-80DB-DF0F62C07196

P921

Q34107767-F41A0A42-3205-4A1F-BF69-B1FBA0D45A39

P932

Q34107767-FB2E1733-6991-4D58-91D7-4EF6DA95A9F1

P356

1756-0500-4-553

P1433

BMC Research Notes

P1476

Recombinant human erythropoiet ...... carcinoma cell lines in vitro

@en

P2093

Elham Rahimy

http://www.w3.org/2001/XMLSchema#string

Eric Abhold

http://www.w3.org/2001/XMLSchema#string

Katherine J Blair

http://www.w3.org/2001/XMLSchema#string

Kevin T Brumund

http://www.w3.org/2001/XMLSchema#string

Michael A Yu

http://www.w3.org/2001/XMLSchema#string

Robert A Weisman

http://www.w3.org/2001/XMLSchema#string

Weg M Ongkeko

http://www.w3.org/2001/XMLSchema#string

P2860

Erythropoietin signaling promotes invasiveness of human head and neck squamous cell carcinoma.

Functional erythropoietin autocrine loop in melanoma

Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression

Erythropoietin/erythropoietin-receptor system is involved in angiogenesis in human hepatocellular carcinoma.

Erythropoietin biology in cancer.

Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis

A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.

Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia.

Impact of erythropoietin on the effects of irradiation under hypoxia.

Recombinant erythropoietin differently affects proliferation of mesothelioma cells but not sensitivity to cisplatin and pemetrexed.

P2888

1756-0500-4-553

P304

553

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1756-0500-4-553

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Jessica Wang-Rodriguez

P577

2011-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51905403

http://www.w3.org/2001/XMLSchema#string

P6179

1021353210

http://www.w3.org/2001/XMLSchema#string

P698

22188703

http://www.w3.org/2001/XMLSchema#string

P921

P932

3285115

http://www.w3.org/2001/XMLSchema#string